Patrizia Casalini

Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients.

Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients.

Journal: Scientific reports
Published: October 19, 2018

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer.

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer.

Journal: Journal of cellular physiology
Published: April 25, 2018

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

Journal: Oncotarget
Published: December 30, 2017

Lipid accumulation in human breast cancer cells injured by iron depletors.

Lipid accumulation in human breast cancer cells injured by iron depletors.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 09, 2017

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.

Journal: BMC cancer
Published: October 04, 2017

Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.

Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.

Journal: Cancer immunology research
Published: July 20, 2017

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.

Journal: Oncogene
Published: June 24, 2016

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

Journal: Cancer letters
Published: April 14, 2016

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

Journal: Cancer research
Published: January 21, 2016

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.

Journal: Oncotarget
Published: September 10, 2015

Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.

Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.

Journal: Molecular oncology
Published: July 17, 2015

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.

Journal: Oncotarget
Published: May 09, 2014
Showing 1-12 of 26

Last Updated: 09/26/2026